PTC Therapeutics shares are trading higher after Morgan Stanley upgraded the stock from Underweight to Equal-Weight and raised its price target from $28 to $30.
PTC Therapeutics, Inc. +2.29%
PTC Therapeutics, Inc. PTCT | 39.32 | +2.29% |
PTC Therapeutics shares are trading higher after Morgan Stanley upgraded the stock from Underweight to Equal-Weight and raised its price target from $28 to $30.